Parasite Drugs Cut MS Relapses: Overlooked Research Reveals the True Cause of MS

For over 100 years, evidence has been quietly pointing to one shocking truth: multiple sclerosis (MS) is not an autoimmune disease, but an infectious disease caused by a parasitic infestation.

Parasite drugs don’t just fight infections — they have been shown to cut MS relapses, slow disability, and even promote remyelination. This overlooked evidence changes everything about how we view and treat MS.

Parasites Linked to MS

Parasites shown to infect MS patients include:

• Worms: filarial roundworms and tapeworms discovered in the CNS of MS patients
• Bacteria: such as Borrelia (Lyme disease)
• Fungi: mold and yeast commonly seen in MS
• Protozoa (Protists): single-cell parasites like plasmodia (causes malaria), Babesia, Toxoplasma.

Protozoa are especially important in MS. They infect red blood cells (RBCs), making them sticky and prone to blocking blood vessels, including in the brain. This can cause obstructions, ruptures, and bleeds. Research shows MS lesions are always centered around a blood vessel, often with iron rings — likely from ruptured RBCs.

Historic Evidence

• 1880s–1890s: At least 75 papers linked malaria-like protozoa to MS
• 1899: Dr. Mannaberg proposed MS was caused by a malarial-type infection
• 1920s–1930s: Malaria drugs improved MS patients’ symptoms
• Modern era: Dr. Fry (Fry Laboratories) discovered a novel malaria-like protist in MS patients, forming biofilms and behaving like both protozoa and worms.

Hydroxychloroquine: A Breakthrough in PPMS

In a 2021 University of Calgary study, the malaria drug hydroxychloroquine (HCQ) was tested in 35 people with primary progressive MS (PPMS).

• Normally, 40% (14 patients) should have worsened in walking ability over 18 months
• With HCQ, only 23% (8 patients) declined
• That’s a 42% reduction in expected disability progression.

No MS drug to date has shown this level of benefit in PPMS. Yet neurologists are not recommending HCQ.

Levamisole: Cutting Relapses in Half

Two long-term, double-blind, placebo-controlled trials revealed the power of the parasite drug levamisole in reducing MS relapses.

Study #1 (1982, 3 years, 85 patients):

• Placebo patients’ disability worsened significantly.
• Levamisole patients remained stable.

Study #2 (1991, 4 years, 41 patients):

• 36% of levamisole patients relapsed compared to 74% in the placebo group.
• That’s an absolute reduction of 38%.
• And a relative risk reduction of 51%.

No modern MS drug offers this kind of long-term relapse protection with such a favorable safety profile.

Ivermectin: Promoting Repair

In animal studies, ivermectin didn’t just reduce disease activity — it helped the brain switch from inflammation to repair:

• It caused microglia to change from a inflammatory state into a healing one
• It promoted remyelination — actual repair of damaged nerves.

Why This Matters

Let’s compare:

• HCQ: 42% fewer patients declined in PPMS
• Levamisole: 51% fewer relapses in treated patients
• Ivermectin: Promoted remyelination in MS models.

These numbers are extraordinary. Yet they’ve been ignored for decades because they don’t fit the autoimmune model of MS.

Path to Recovery

Parasite drugs provide strong evidence that MS is an infectious disease caused by parasites. But to truly recover, we must follow a proven plan:

1. Make them less active with a low-carb diet
2. Support the body
3. Treat parasites effectively — using a combination of drugs, herbs, and oxygen therapies
4. Live a healthy lifestyle — activity, detox, and lifestyle changes.

This is how I’ve lived MS-free for 35+ years, and how hundreds of our students are also recovering.

Final Word

When parasite drugs show 42% less disability and 51% fewer relapses, the message is clear:

MS is caused by parasitic infections — and recovery is possible.

 

There are real solutions to recover from parasites today!

To restore health, we must focus on treating the cause of inflammation, which are parasites. First, identify the enemy (parasites), then support the body and treat the parasites while following a holistic approach. When parasitic infections are treated effectively, we can overcome inflammation or disease.

If you’re frustrated with the fact that our standard of care STILL doesn’t offer a real solution for treating MS and other diseases, then click on the link below to watch Pam Bartha’s free masterclass training and discover REAL solutions that have allowed Pam and many others to live free from MS and other diseases.

CLICK Here to watch Pam’s masterclass training

 

References

Koch MW, Kaur S, Sage K, Kim J, Levesque-Roy M, Cerchiaro G, Yong VW, Cutter GR, Metz LM. Hydroxychloroquine for Primary Progressive Multiple Sclerosis. Ann Neurol. 2021;90(6):940-948. doi:10.1002/ana.26239.
URL: https://pubmed.ncbi.nlm.nih.gov/34590328/

Gonsette RE, Demonty L, Delmotte P, Decree J, de Cock W, Verhaeghen H, Symoens J. Modulation of immunity in multiple sclerosis: a double-blind levamisole–placebo controlled study in 85 patients. J Neurol. 1982;228(1):65-72. doi:10.1007/BF00313411.
URL: https://pubmed.ncbi.nlm.nih.gov/6184460

Massaro AR, Cioffi RP, Laudisio A, Schiavino D, Mariani M. Four year double-blind controlled study of levamisole in multiple sclerosis. Ital J Neurol Sci. 1990;11(6):595-599. doi:10.1007/BF02337444.
URL: https://pubmed.ncbi.nlm.nih.gov/2081685/

Zabala A, Vázquez-Villoldo N, Rissiek B, et al. P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis. EMBO Mol Med. 2018;10(8):e8743. doi:10.15252/emmm.201708743.
URL: https://pubmed.ncbi.nlm.nih.gov/29973381/